about
Current and emerging treatment options for patients with relapsed myelomaAntithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization.Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.Safety of anticoagulation in thrombocytopenic patients with hematologic malignancies: A case series.Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohort.Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemiaChoosing treatment options for patients with relapsed/refractory multiple myeloma.Contributing role of extracellular vesicles on vascular endothelium haemostatic balance in cancer.CT and MRI evaluation of cardiac complications in patients with hematologic diseases: a pictorial review.Thrombosis in leukemia: incidence, causes, and practical management.Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients.Identification of target gene of venous thromboembolism in patients with lymphoma via microarray analysis.Management of venous thromboembolism in patients with acute leukemia at high bleeding risk: a multi-center study.The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model.
P2860
Q26830878-8073EC44-806E-4610-9DED-E55CF648E36EQ33416407-9192298C-FC5E-436C-B77A-F613FF876C3DQ33417504-252F5032-6AE9-445F-9C7F-5A12EB7045FAQ33429840-F891E25D-0DB7-4248-B1FC-86D80BFEEC63Q33440816-AA496FD7-412B-487D-8047-B2B6B763C758Q37152911-E249B4E3-04B7-4801-B370-4D0ABE4044FEQ38170453-669B53D6-0632-496B-BCFE-33D0B9E4D58CQ38232072-37CE1F1B-55EF-4C97-A029-5E84E8581C98Q38344263-EE82C635-103E-4A04-84AC-78D4D4647675Q38364922-2DA85F7F-793F-4407-9355-28C8B7AD301AQ39629675-93EFB085-33F2-4706-B15B-E1696BFC641CQ41618470-062683A4-3005-4E29-B8C4-4B317499615BQ41759311-043FD92B-43D5-4EF4-BEE2-AC234CEE5068Q55401609-0AAD0507-7743-4CA2-908C-17CDEA14C076
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hematologic malignancies and thrombosis.
@ast
Hematologic malignancies and thrombosis.
@en
type
label
Hematologic malignancies and thrombosis.
@ast
Hematologic malignancies and thrombosis.
@en
prefLabel
Hematologic malignancies and thrombosis.
@ast
Hematologic malignancies and thrombosis.
@en
P1433
P1476
Hematologic malignancies and thrombosis.
@en
P2093
P304
P356
10.1016/J.THROMRES.2011.11.034
P577
2011-12-22T00:00:00Z